Recap: Intra-Cellular Therapies Q1 Earnings

Intra-Cellular Therapies ITCI reported its Q1 earnings results on Tuesday, May 10, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.

Intra-Cellular Therapies beat estimated earnings by 15.22%, reporting an EPS of $-0.78 versus an estimate of $-0.92.

Revenue was up $19.12 million from the same period last year.

Last quarter the company missed on EPS by $0.05 which was followed by a 0.97% increase in the share price the next day.

Here's a look at Intra-Cellular Therapies's past performance:

Quarter	Q4 2021	Q3 2021	Q2 2021	Q1 2021
EPS Estimate	-1	-0.92	-0.80	-0.80
EPS Actual	-1.05	-0.95	-0.85	-0.65
Revenue Estimate	25.37M	22.12M	19.44M	16.50M
Revenue Actual	25.67M	22.21M	20.05M	15.88M

To track all earnings releases for Intra-Cellular Therapies visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar